Chemotherapy Plus Concomitant Low-Dose Fractionated Radiotherapy as Second-Line Treatment for Recurrent or Progressive Glioblastoma After Temozolomide-Based Chemoradiation: A Pilot Study.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.2083
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2011
Authors
Publisher
American Society of Clinical Oncology (ASCO)